Prevention of type 2 diabetes

International Journal of Clinical Practice, Supplement

Volumn , Issue 113, 2000, Pages 35-39

  Yale, J F ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METFORMIN; PIOGLITAZONE; RAMIPRIL; ROSIGLITAZONE; THIAZOLIDINE DERIVATIVE;

COST; DIABETOGENESIS; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; PANCREAS ISLET BETA CELL; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; VASCULAR DISEASE;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; RANDOMIZED CONTROLLED TRIALS; THIAZOLES;

EID: 0033658463     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults
2. Diabetes in America. 2nd Edition
3. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
5. Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM
6. Insulin resistance and compensatory hyperinsulinemia: Role in hypertension, dyslipidemia, and coronary heart disease
7. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
8. Comparison of diabetes diagnostic categories in the US population according to 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria
9. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies
10. Impaired fasting glucose or impaired glucose tolerance: What best predicts future diabetes?
11. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus
12. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise
13. The Da Qing IGT and diabetes study. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance
14. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
15. ACE inhibition and glucose transport in insulin-resistant muscle: Roles of bradykinin and nitric oxide
16. Insulin resistance in adipocytes from spontaneously hypertensive rats: Effect of long-term treatment with enalapril and losartan
17. The Diabetes Prevention Program: Design and methods for a clinical trial in the prevention of type 2 diabetes
18. Inhibition of hepatic gluconeogenesis by metformin: Synergism with insulin
19. The STOP-NIDDM trial: An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: Rationale, design, and preliminary screening data
20. Acarbose: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential
21. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance
22. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial
23. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
24. Rosiglitazone is superior to glyburide in reducing fasting plasma glucose after 1 year of treatment in type 2 diabetic patients